Uithoorn, The Netherlands (ots/PRNewswire) - A leader in technology-based sales support tools, HOYA is proud to introduce its latest innovation: the HOYA Vision Simulator offers wearers the ability to experience their new lenses before they buy them, right in the store. Using wearers' actual prescription, the HOYA Vision Simulator provides a highly accurate, 3D vision experience, visualising the optical effects of the ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - The first selective alpha-2A adrenergic receptor agonist licensed for the treatment of ADHD in the EU Shire today announced that the European Commission granted Marketing Authorisation for once-daily, non-stimulant INTUNIV(R) (guanfacine hydrochloride prolonged release ...
Chertsey, England (ots/PRNewswire) - Astellas Pharma Europe Ltd. today announced the European Commission has granted approval for a label extension for QUTENZA[TM] (capsaicin 8% patch) to include the treatment of adult diabetic patients with peripheral neuropathic pain, either alone or in combination with other ...
Lyon, France (ots/PRNewswire) - A relevant and comprehensive approach on the benefits of vaccines on healthcare systems sustainability and economic growth Sanofi Pasteur MSD is proud to announce the publication of a supplement dedicated to the economic value of vaccination in the Journal of Market Access and Health Policy. The series of 7 articles has been developed ...
Darmstadt, Germany And Manila, Philippines (ots/PRNewswire) - - Merck Philippines joins forces with Health Department and Thyroid Association to put spotlight on health and wellbeing of Filipino women Merck Serono, the biopharmaceutical business of Merck, today announced the launch of a partnership with the Department of Health, Philippines, and the Philippine ...
Stockholm, Sweden (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Abstract #75 Findings from a head-to-head trial comparing Victoza(R) (liraglutide) and lixisenatide, both in combination with metformin, demonstrated a ...
Stockholm, Sweden (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication Abstract #645 Today, new data from a post-hoc analysis of the phase 3a SCALE(TM) clinical development programme were presented at the 51st European Association ...
Stockholm (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. New data presented today at the 51st annual meeting of the European Association for the Study of Diabetes (EASD) show that patients with type 2 diabetes receiving the ...
Stockholm, Sweden (ots/PRNewswire) - Results presented today at the European Association for the Study of Diabetes (EASD) showed that increased awareness about how patients' and physicians' perceptions of control differ, could benefit physician-patient communication and improve diabetes management.[1] New findings ...
Stockholm, Sweden (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. New findings from the DUAL(TM) V phase 3b clinical trial showed greater improvements in treatment-related satisfaction and patient-reported physical ...
Uithoorn, Netherlands (ots/PRNewswire) - HOYA Corporation's Vision Care Division, a key player in the global market for ophthalmic lenses, is pleased to announce the creation of HOYA Turkey Optik Lens San. Tic. AS as an affiliate of HOYA Vision Care Europe. The subsidiary has been established to provide better service and develop the local optical market. HOYA sees great opportunities to expand its business in Turkey ...
Chertsey, England (ots/PRNewswire) - $150,000 Grant will be awarded on Monday 14th September The Astellas European Foundation has announced the shortlist for the 2015 Transplantation Grant. The Grant programme supports medical and related scientific programmes which contribute to advancements in transplantation. The six programme finalists are led by institutions ...
Helsingborg, Sweden (ots/PRNewswire) - The Swedish company Laccure AB has developed a breakthrough women's health product that is effective, safe and user-friendly. Laccure's owners are now aiming to divest the company to a buyer with appropriate resources to launch the product. The manufacturing process for the new product, Laccure(R) Pessary, has now been scaled up ...
Tokyo (ots/PRNewswire) - The National Institute for Health and Care Excellence (NICE), the medicines cost-effectiveness body for England and Wales, has today recommended a new treatment to help patients suffering from blood clots in the legs and lungs.[1] Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) ...
Munich (ots/PRNewswire) - FOR EU MEDIA ONLY. NOT FOR UK MEDIA. - Daiichi Sankyo announces enrollment of first patient in ETNA-AF-Europe and the commencement of ETNA-VTE-Europe, two regional registries to collect robust information on how once-daily LIXIANA(R) is being used in real world settings - ETNA is a Daiichi Sankyo global initiative which will collect data ...
London (ots/PRNewswire) - A new UK company focused on acquiring, rapidly developing and commercialising innovative medicines to transform patient quality of life and improve human health Highly experienced management team; blue chip investors Mereo BioPharma Group Ltd ("Mereo"), a recently-formed speciality ...
Heidelberg (ots) - BioMed X Innovation Center announced today that they have extended their collaboration with Merck Serono, the biopharmaceuticals business of Merck, on new approaches for cancer therapy. Based on the results presented at the biannual meeting on July 10th in Heidelberg, Germany, Merck Serono decided to extend the funding of the first two international research groups for a third year. BioMed X and Merck ...
Calgary, Alberta (ots/PRNewswire) - - TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix") announced today that it has closed the previously-announced private placement with Shenzhen Hepalink Pharmaceutical Co., Ltd. ("Hepalink") and Eastern Capital Limited ("Eastern"). Under the terms of the transaction, Hepalink subscribed for 13,270,000 units, each unit ...
Hong Kong (ots/PRNewswire) - Study to enroll 436 patients at up to 20 sites throughout China OrbusNeich, a global company specializing in the provision of life-changing vascular solutions, has announced that the first patient has been enrolled in the clinical study in China of its COMBO(TM) Dual Therapy Stent. The China Recovery Study is designed to evaluate the ...
Intrepid 24/7 & Ingle International Inc.
Toronto (ots/PRNewswire) - Intrepid 24/7, a global medical, security, and travel assistance company within the Ingle International group of companies, is changing the landscape of business travel with its award-winning, white-labelled native mobile and web application, Travel Navigator(TM). Travel Navigator(TM) was ...
Milan (ots/PRNewswire) - The deal will speed up the commercialization of Xadago(R) for the treatment of Parkinson's Disease Nigaard is a pharmaceutical company well established in Denmark, Norway, Sweden, Iceland and Finland Zambon S.p.A., an international pharmaceutical company strongly committed to the Central Nervous System (CNS) therapeutic area and the Respiratory area with a focus on Rare Diseases, announced today ...
Calgary, Alberta (ots/PRNewswire) - TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix") announced today that it has closed a license agreement and formally entered into a definitive stock purchase agreement with Shenzhen Hepalink Pharmaceutical Co., Ltd. ("Hepalink"). The closing of the stock purchase ...
Teva Pharmaceutical Industries Ltd.
Amsterdam (ots/PRNewswire) - Teva Pharmaceutical Industries Ltd. today announced that its DuoResp Spiromax(R) inhaler has won silver at the 2015 Medical Design Excellence Awards (MDEA). The awards recognize significant advances in medical product design that improve the quality of healthcare delivery. DuoResp Spiromax(R) (budesonide/formoterol fumarate dihydrate) is a ...
Nuremberg, Germany (ots/PRNewswire) - - Internationally, only 16 percent of people are completely satisfied with the amount of leisure time they have. - America, Canada and UK have highest percentage of people who are satisfied; Russia and Japan have highest percentage dissatisfied. The busy pace of life is a popular complaint for many people. But findings released by ...
Lyon, France (ots/PRNewswire) - MSD, known as Merck in the United States and Canada and Sanofi Pasteur, the vaccines division of Sanofi , the two partner companies in Sanofi Pasteur MSD, announce today the appointment of David Khougazian as president of Sanofi Pasteur MSD. To view the Multimedia News Release, please click: ...
Bagsværd, Denmark (ots/PRNewswire) - Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the expanded use of Levemir(R) (insulin detemir) in children with diabetes as young as one year old. (Logo: http://photos.prnewswire.com/prnh/20141103/713759 ) There are an estimated 497,100 children living ...
Tokyo (ots/PRNewswire) - Press release not intended for US and UK media - EU approval paves the way for LIXIANA(R) (edoxaban) to be made available across all European member states - Marketing authorisation is based on data from the ENGAGE AF-TIMI 48 and Hokusai-VTE studies, the largest single comparative global ...
Toronto (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Today, at the International Society on Thrombosis and Haemostasis (ISTH) 2015 Congress, Novo Nordisk announced the latest interim data from the guardian(TM)2 extension ...
Milan (ots/PRNewswire) - The new generation of subcutaneous defibrillators selected as most innovative in the field of cardiac electrophysiology. Attendees of EHRA EUROPACE-CARDIOSTIM 2015, a global medical conference held recently in Milan, Italy, have selected the EMBLEM(TM) S-ICD System as the most innovative ...
Calgary, Alberta (ots/PRNewswire) - TSX Exchange Symbol: RVX Resverlogix Corp. today announced that following recent meetings with various European regulatory bodies, the first confirmation for our Phase 3 clinical plan has officially been received. A further regulatory and protocol design update will be provided to the market post the approval of additional regulatory ...